Alan Leong
Alan Leong is the cofounder and CEO of BioWatch LLC. The company's services and monthly journal, BioWatch News, are for those who invest and have a fascination with seeing what’s next in the biotech industry. It features individual companies and also introduces readers to edgy topics and sectors. Past issues featured alopecia, metabolic syndrome, the future of biotech and pet meds. Before BioWatch, Leong was cofounder of Biotech Stock Research (BSR), a boutique service for life science investors. He published more than 1,500 pages for BSR and wrote more than 45 main feature stories, plus numerous alerts, company updates and annual reviews. Leong has also been an award-winning instructor within the University of Washington system, teaching courses in entrepreneurship, technology forecasting and early-stage investing.
Recent Quotes
"RP had successful proof of concept with RCH-01 with restoring hair."
—
The Life Sciences Report Interview with Alan Leong
(1/20/16)
more >
"HNSN's systems should increase the precision and safety of the surgical procedures."
—
The Life Sciences Report Interview with Alan Leong
(1/20/16)
more >
"CPHR is a long-term story for value investors as it improves revenue and margins."
—
The Life Sciences Report Interview with Alan Leong
(1/20/16)
more >
"An approval of SNSS' vosaroxin in the EU would be the surprise upside to monitor."
—
The Life Sciences Report Interview with Alan Leong
(1/20/16)
more >
"RNN is in full swing; 2016 is going to be an interesting year."
—
The Life Sciences Report Interview with Alan Leong
(1/20/16)
more >
"We like CTRV's team, and we like the products."
—
The Life Sciences Report Interview with Alan Leong
(1/20/16)
more >
"If RVX is successful with RVX-208, there is a lot of upside left."
—
The Life Sciences Report Interview with Alan Leong
(1/20/16)
more >
"SNSS was encouraged by European Union regulatory staff to submit for approval of Qinprezo."
—
The Life Sciences Report Interview with Alan Leong
(9/9/15)
more >
